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Aquaporin-7 (AQP7) is expressed in adipose tissue, permeated by water and glycerol, and is involved
in lipid metabolism. AQP7-null mice develop obesity, insulin resistance, and adipocyte hypertrophy.
Here, we show that AQP7 is expressed in adipocyte plasma membranes, and is re-localized to intra-
cellular membranes in response to catecholamine in mouse white adipose tissue. We found that
internalization of AQP7 was induced by PKA activation and comparative gene identiﬁcation 58
(CGI-58). This relocation was conﬁrmed by functional studies in 3T3-L1 adipocytes. Collectively,
these results suggest that AQP7 makes several contributions to adipocyte metabolism, in both cor-
tical and intracellular membranes.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
White adipocytes play an indispensable role in controlling
whole body metabolism via their management of lipid storage, as
well as the production of bioactive peptides and the regulation of
insulin sensitivity [1,2]. In adipocytes, lipids are mainly stored as
triacylglycerol (TG) in lipid droplets (LDs). Recent studies revealed
that the surfaces of LDs and LD-associated endoplasmic reticulum
(ER) are platforms where various proteins are associated and
engaged in lipolysis and lipogenesis [3–5]. For example, the associ-
ation of adipose triglyceride lipase (ATGL) with comparative gene
identiﬁcation 58 (CGI-58) at the LD surface is the initiation step
in TG catabolism [6]. The glycerol-3-phosphate acyltransferase
GPAT4, which catalyzes the rate-limiting step in TG synthesis,
functions at the ER and forming LDs [7,8]. The subcellular distribu-
tion of glycerol and the mechanism controlling its local concentra-
tion in lipolytic or lipogenetic adipocytes remain unclear.
Aquaporin-7 (AQP7) is an aquaglyceroporin expressed in adi-
pose tissues [9–11]. Dysregulation of glycerol concentration is aremarkable contributing factor to the development of metabolic
disease. This is supported by the observation that AQP7-null mice
exhibit marked hypertrophy of adipocytes, obesity and diabetes
[12,13]. Furthermore, the activity of glycerol kinase, which is nor-
mally suppressed in adipocytes, is augmented in AQP7-null mouse
adipocytes, accompanied by the accumulation of glycerol and TG
and hypertrophy [12]. The involvement of AQP7 in adipocyte lipid
metabolism is also supported by the ﬁndings that AQP7 binds LDs
in 3T3-L1 adipocytes [14] and that AQP7 expression improves adi-
pose tissue insulin resistance [15]. However, the extent and the
subcellular localization of AQP7 in adipose tissue remain contro-
versial [16]: (i) We and others reported the phenotype of AQP7-
null mice, which displays the metabolic disorder in adipocytes
[12,13]; and (ii) another study [17] demonstrated restricted
AQP7 expression in the capillary endothelia of adipose tissue, but
not in the surrounding adipocytes of mouse adipose tissue, sug-
gesting a non-cell autonomous role for AQP7 in promoting antihy-
pertrophic effects.
In this study, we ﬁrst aimed to investigate the reasons for the
discrepancies in the expression proﬁles where adipocyte metabo-
lism was affected by AQP7 in nearby capillary endothelia. Our
results demonstrated that AQP7 is expressed in mouse white adi-
pocytes, and that AQP7 translocates from cortical to intracellular
membranes during lipolysis. We identiﬁed the signaling mecha-
nism controlling this translocation of AQP7.
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2.1. Mouse adipose tissue
All animal work was conducted in accordance with relevant
guidelines and regulations. The generation of AQP7-null mice has
been described previously [18]. White adipose tissues isolated
from inguinal tissues of AQP7+/+ and AQP7-null C57BL/6 mice
were cut into small pieces (less than 2 mm thick) and used for
immunoﬂuorescence imaging. To analyze AQP7 translocation, the
small pieces of tissue were exposed to media containing 1 lm
insulin or 10 lm norepinephrine and incubated at 37 C for 3 h
with shaking for aeration. Prior to ﬁxation, the adipocytes in the
tissue were conﬁrmed to be at least 95% viable by calcein-AM
incorporation.
2.2. Cell culture and differentiation
3T3-L1 cells were differentiated into adipocytes as described by
Jain et al. [19]. The cells were transfected with expression plasmids
by electroporation on 8 days after the induction of differentiation,
incubated for 2 days, and then analyzed by microscopic imaging.
2.3. Immunohistochemistry and immunocytochemistry
Tissues and 3T3-L1 adipocytes were ﬁxed using 10% trichloro-
acetic acid (TCA) as described by Hayashi et al. [20]. The afﬁnity-
puriﬁed anti-mouse AQP7 antibody (1246) has been previously
characterized [21].Fig. 1. Optimization of the immunostaining method to visualize the intracellular localiza
3T3-L1 cells. Reverse transcription-PCR for 3T3-L1 adipocytes/pre-adipocytes was perfor
weight marker; lanes 2, 3, 5, 7, 9, 11, 13: control 3T3-L1 pre-adipocytes; lanes 4, 6, 8, 1
speciﬁc recognition of aquaporin-7 (AQP7) protein by the anti-AQP7 antibody was c
intracellular ﬂow cytometric analysis are shown. Top panel: control 3T3-L1 cells transf
immunostained with an anti-AQP7 primary antibody and an Alexa488-labeled secondar
mCherry, ﬁxed with TCA, and immunostained with an anti-AQP7 primary antibody and
ﬂuorescence intensity (excitation 488 nm; emission 525 ± 15 nm) of each cell in a comm
AQP7-dependent manner. Both histograms include 15000 cells. (C) Comparison of the im
paraformaldehyde (PFA). The immunoreactivity of the anti-AQP7 antibody (left panel) a
also compared. The cells were labeled with anti-AQP7 and Alexa555-conjugated anti-ra2.4. Imaging
During live imaging of lipolysis, the localization of AQP7-EGFP
was observed with simultaneous monitoring of lipids using coher-
ent anti-Stokes Raman scattering (CARS) microscopy [22]. Lipolysis
was stimulated by bath- applications of 5 lm forskolin or 10 lm
norepinephrine prepared in HEPES-buffered DMEM-F12 (Life tech-
nologies) medium containing 2% fetal bovine serum at 37 C. The
images were analyzed using FluoView software (ver. 2.01; Olym-
pus), and Metamorph software (ver. 7.7; Molecular devices, Down-
ingtown, PA).
Full methods and associated references are available in SI Mate-
rials and methods.3. Results
3.1. Optimized staining of adipocytes with an anti-AQP7 antibody
Immunoﬂuorescence imaging was optimized to detect a low
level of AQP7 expression. TCA-ﬁxation can improve the detection
sensitivity similar to cases of ezrin/radixin/moesin or RhoA
labeling [20,23]. First, we checked the mRNA expression of aqp7
in adipocyte differentiation-induced 3T3-L1 cells. The expression
was observed speciﬁcally in 3T3-L1 adipocytes (Fig. 1A). Then,
the speciﬁcity of the anti-AQP7 antibody in TCA-ﬁxed samples
was conﬁrmed by a cell assay, in addition to a speciﬁcity test that
we have performed in a previous study of paraformaldehyde (PFA)-
ﬁxed samples [21]. Intracellular ﬂow cytometry analysis showed ation of AQP7 in 3T3-L1 cells. (A) Expression of aqp7 mRNA in differentiation-induced
med using primers speciﬁc for aqp7 and for the control, b-actin (lane 1: molecular
0, 12, 14: 3T3-L1 adipocytes). Day: days after induction of differentiation. (B) The
onﬁrmed using cells selectively expressing AQP7. The normalized histograms of
ected and partially expressing mCherry, ﬁxed with trichloroacetic acid (TCA), and
y antibody. Bottom panel: 3T3-L1 cells transfected and partially expressing AQP7-
an Alexa488-labeled secondary antibody. Note that the horizontal axis shows the
on logarithm; the single peak separated from the background signals arises in an
munoreactivity of the anti-AQP7 antibody in 3T3-L1 adipocytes ﬁxed with TCA or
nd autoﬂuorescence (right panel) in 3T3-L1 adipocytes ﬁxed with TCA or PFA were
bbit antibodies (left panel). Bars = 10 lm.
Fig. 2. Cellular and subcellular localization of AQP7 in white adipose tissue. (A) Immunohistochemical staining of AQP7 in newborn (p1) mouse adipose tissue isolated from
inguinal white adipose tissues. The cortical membrane and cytosolic region of adipocytes containing multilocular small lipid droplets are displayed. The lipids are visualized
by CARS microscopy (center panel). An overlay image is shown (right panel). (B) Immunohistochemical AQP7 staining in AQP7-null p1 mouse adipose tissues as a negative
control. (C) Mouse (p5) adipocytes labeled with an anti-AQP7 antibody (left panel) and BODIPY 493/503 (center panel), and an overlay image (right panel). 3D reconstructions
of 2D confocal images (ﬁve slices, 1  4 lm) are shown. (D) Immunoﬂuorescence detection of AQP7 at the plasma membrane of white adipocytes. Adult mouse white adipose
tissue labeled with Alexa488-cholera toxin subunit b (CTb) and an anti-AQP7 antibody. An overlay image is shown (regions of overlap are shown in white). Lipids visualized
by CARS microscopy and an overlay image with anti-AQP7 antibody labeling are shown. The arrows indicate blood vessels. Bars = 10 lm.
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teristic of background noise (Fig. 1B). These results indicate that
the anti-AQP7 antibody speciﬁcally recognized AQP7 in TCA-ﬁxed
3T3-L1 cells.
Next, ﬁxation methods for ﬂuorescence microscopy were com-
pared using 3T3-L1 adipocytes. The anti-AQP7 antibody ﬂuores-
cent signal was considerably stronger in cells ﬁxed with 10% TCA
than in cells ﬁxed with PFA, and was primarily observed on plasma
membranes (Fig. 1C, left). In addition, the ﬂuorophore to which the
secondary antibody was conjugated needed to be carefully selected
for accurate microscopy because 3T3-L1 adipocytes emanated con-
siderable green autoﬂuorescence (Fig. 1C, right). Accordingly, green
ﬂuorophores should be used carefully and those of a longer wave-
length are better to be selected. Collectively, the optimized immu-
noﬂuorescence imaging enabled us to determine the intracellular
distribution of AQP7.
3.2. AQP7 expression in mouse white adipocytes
Using the aforementioned method, we observed the immunore-
activity of the anti-AQP7 antibody in mouse white adipocytes
(Fig. 2A–D). One obstacle in this analysis is that anymass inside adi-pocytes may be confused with cortical structures because the cyto-
solic space is occupied by a large unilocular LD. To overcome any
possible artifacts inherent to large unilocular LDs, we selectively
observed young white adipocytes that each containing several
small LDs. CARSmicroscopy allowed the identiﬁcation of white adi-
pocytes containing LDs without the artiﬁcial fusion of multilocular
LDs [24–27]. Immunoﬂuorescence microscopy demonstrated that
AQP7 was expressed and cortically localized in adipocytes isolated
from 1-day-old wild-type mice (Fig. 2A). Negligible signals were
observed in adipose tissue of AQP7-null mice (Fig. 2B). AQP7
expression in white adipocytes was further conﬁrmed by 3D recon-
struction of the microscopy images. Almost all adipocytes in mouse
(p5) inguinal white adipose tissues contained a unilocular per cell.
The 3D reconstruction showed that each adipocyte is covered by
the immunoﬂuorescence of AQP7 (Fig. 2C). AQP7 localization at
the plasma membrane was supported by double staining with a
ﬂuorescent conjugate of cholera toxin subunit b (CTb) that labels
the plasma membrane (Fig. 2D). Relatively strong ﬂuorescence
was observed in capillaries (Fig. 2A, C, and D), which is consistent
with our previous observations [17]. These results indicate that
AQP7 is expressed in adipocyte plasma membranes at a lower level
than in capillary endothelia.
Fig. 3. Translocation of AQP7 from cortical to intracellular membranes during lipolysis. (A) Representative distribution patterns of AQP7 in isolated p3 mouse adipose tissues
after 3 h of exposure to media containing 1 lm insulin or 10 lm norepinephrine. Overlay images of Hoechst labeling (blue: nuclei), BODIPY 493/503 labeling (red: lipid
droplets), and anti-AQP7 antibody labeling (green) are shown. The arrowheads show the cytoplasmic side of adipocyte nuclei, where the intracellular localization is
unambiguously identiﬁed. (B and C) Representative images and quantiﬁcation of the lipolysis-dependent increase in the intracellular localization of AQP7. The ratio of
cytoplasmic versus cortical immunoﬂuorescence labeling of AQP7 observed using the envelope region of nucleoli. The mean immunoﬂuorescence intensity within the
enclosed regions was compared and the ratio was plotted. The data obtained from thirty adipocytes (ten randomly selected adipocytes per sample, three separate counts)
were plotted. The box plot shows the mean value (line), 25th and 75th percentiles (boxes), and 5th and 95th percentiles (whiskers). ⁄⁄P < 0.001 by the Mann–Whitney U-test.
(D and E) Representative images and quantiﬁcation of the percentage of adipocytes showing internalized AQP7 around multilocular LDs (anti-AQP7 antibody labeling, green).
The error bars represent the standard deviation of four separate counts (50 cells each). Values are represented as mean ± standard deviation (four separate counts, 50 cells
each). Bars = 10 lm.
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Next, we tested if the subcellular localization of AQP7 is altered
during lipolysis. The adipose tissues isolated from 3-day old mice
were used, which still possess some multilocular LDs and could
be more easily isolated than the tissue of 1-day old mice. The iso-
lated adipose tissue was exposed to insulin or norepinephrine-con-
taining media and incubated for 3 h (see Section 2). AQP7 was
distinctly localized to the cell cortex of insulin-stimulated adipo-
cytes (Fig. 3A, left panels). Conversely, AQP7 was observed in the
intracellular region surrounding the LDs in response to norepineph-
rine (Fig. 3A, right panels). The distributions of AQP7 in the cyto-
plasmic and outer membranes were readily observed in the area
of the nuclear envelope (denoted by the arrowheads in Fig. 3A;
Fig. 3B and C), although identiﬁcation of the cortical and cytoplas-
mic regions was hampered by large LDs in adipocytes. The percent-
age of adipocytes showing internalized AQP7 markedly differedbetween insulin-stimulated and norepinephrine-stimulated adi-
pose tissues (Fig. 3D and E). These results suggest that lipolysis acti-
vation induces AQP7 translocation from the cortical to inner
membranes.
3.4. Control of AQP7 localization by protein kinase A (PKA) and CGI-58
We further investigated the precise distribution and translo-
cation of AQP7 using 3T3-L1 adipocytes that endogenously
express AQP7. In immunoﬂuorescence analysis, AQP7 was mainly
localized at plasma membranes in control cells under basal con-
ditions (Fig. 4A, left panels). In response to forskolin, which acti-
vates adenylyl cyclase to increase the intracellular levels of
cyclic adenosine monophosphate, AQP7 translocated to intracel-
lular regions, particularly around LDs (Fig. 4A, right panels). This
translocation is consistent with the pattern observed in mouse
adipose tissues.
Fig. 4. Translocation of AQP7 from cortical to inner membranes under the controls of PKA and CGI-58. (A) Immunoﬂuorescence of AQP7 showing its cortical or intracellular
distribution in 3T3-L1 adipocytes under basal conditions (left panels) and after 80-min exposure to medium containing 5 lm forskolin (right panels). The enlarged areas
enclosed are shown in the upper panels. Note that the immunoﬂuorescence of AQP7 exhibits the endogenously expressed proteins. LD: lipid droplets, N: nuclei. (B)
Representative images of the translocation of AQP7-EGFP (green) between cortical and inner membranes in 3T3-L1 adipocytes after exposure to medium containing 10 lm
norepinephrine for 3 h. The gray dashed lines denote relatively small LDs. Arrowheads denote the portion of the plasma membrane with a low gradient. (C) Representative
distribution patterns of AQP7-Venus (green) in 3T3-L1 adipocytes co-expressing ECFP–CGI-58 (blue) under basal conditions. Arrowheads denote the portion of the plasma
membrane with a low gradient. (D) Quantiﬁcation of the lipolysis-dependent decrease in the ﬂuorescence intensity of the AQP7 probe localized at the cortex versus that in the
entire cell. (i) 3T3-L1 adipocytes expressing AQP7-EGFP under basal conditions; (ii) 3T3-L1 adipocytes expressing AQP7-EGFP and exposed to medium containing 10 lm
norepinephrine for 3 h; (iii) 3T3-L1 adipocytes expressing AQP7-Venus and ECFP–CGI-58 under basal conditions. The mean ﬂuorescence intensities in the cortical region
(thickness: 1 lm) and the whole entire area of the cell was compared, and the ratio was plotted. ⁄P = 0.00374 by the paired t-test. ⁄⁄P = 0.00164 by the Mann–Whitney U-test.
Data points from the same cell are connected by gray lines. Black lines show mean values. (E and F) Comparison of the water permeability of the plasma membrane in 3T3-L1
cells expressing control ECFP or ECFP–CGI-58. (E) Transmitted light images (left panels), CARSH2O mode images (center panels) of 3T3-L1 adipocytes, and CARSH2O mode line-
scan images showing the area along the red dashed lines in the images (right panels). Gray bars denote extracellular regions. Asterisks denote the points of LDs which exhibit
only slight CARSH2O mode signals. (F) Quantiﬁcation of the CGI-58-dependent increase of the averaged sCARS (decrease in water permeability) for control ECFP and ECFP–CGI-58
3T3-L1 adipocytes or pre-adipocytes. Error bars, mean ± S.D. (n = 12). ⁄P = 0.529  10^(10); ⁄⁄P = 0.620 using a t-test. Scale bars = 10 lm.
612 T. Miyauchi et al. / FEBS Letters 589 (2015) 608–614Next, we examined the distributions of the AQP7 fusion con-
structs AQP7-EGFP, -Venus, and -mCherry. These constructs
showed similar localization proﬁles as endogenously expressed
AQP7 protein (Fig. 4A, left; and B, left panels). Continuous time-
lapse imaging revealed that catecholamine stimulated transloca-
tion of AQP7-EGFP from the plasma membrane to intracellular
regions, including those surrounding LDs (Fig. 4B; and D, i and
ii). These data indicate that lipolysis activation induces the translo-
cation of AQP7 from the cortex to inner membranes.
On the basis of the translocation of AQP7, we hypothesized that
AQP7 distribution might be controlled by the factors involved in
PKA-dependent lipolysis. Catecholamine-induced activation of
PKA is followed by phosphorylation of perilipin 1. CGI-58 is
released from phosphorylated perilipin 1, and partly binds ATGL
on LDs and partly dissociates from LDs, although the physiological
purpose of this transient dissociation from LDs remains unclear
[6,25,28,29]. PKA and perilipin1 also regulate hormone-sensitive
lipase (HSL). Fat-speciﬁc protein 27 (FSP27) binds perilipin1 and
facilitates the growth of LDs. Rab18 mediates LD-ER interactions
[3–5]. We examined which factors affect the subcellular distribu-
tion of AQP7 by testing the effects of perilipin1, CGI-58, ATGL,
HSL, FSP27, and Rab18 on the subcellular distribution of AQP7 in
3T3-L1 adipocytes. The over-expression of CGI-58 resulted in the
re-localization of AQP7 from cortical to intracellular regions in3T3-L1 adipocytes (Fig. 4C). The expression of other factors had
only slight effects on AQP7 localization. AQP7-Venus showed corti-
cal localization in 80% of cells (16 of 20 cells; 5 cells per culture
dish), whereas AQP7 was intracellularly localized in all cells co-
expressing ECFP–CGI-58 (Fig. 4D, iii). ECFP–CGI-58 was mainly
expressed on the surface of LDs and a small amount of the protein
was detected in the cytosol. These data suggest that CGI-58 regu-
lates the translocation and internalization of AQP7 from cortical
to intracellular membranes during lipolysis.
Finally, we investigated the water permeability of 3T3-L1 adipo-
cytes using CARS microscopy. The signaling pathway by which CGI-
58 displaces AQP7 from the cortical membranemay decrease water
permeability because AQP7 is permeated by glycerol and water
[9,18]. Our previous work, using CARSmicroscopywith a quick per-
fusion device for H2O/D2O exchange, showed that the amount of
aquaporin on the plasma membrane can be estimated by measur-
ing the diffusional water permeability of the cell [22]. In 3T3-L1 adi-
pocytes that endogenously express AQP7, the over-expression of
CGI-58 resulted in down-regulation of water permeability (Fig. 4E
and F (gray bars)). This down-regulation was not observed in
3T3-L1 pre-adipocytes (Fig. 4F (white bars)) which only slightly
express AQP7 as shown in Fig. 1A and B. These results suggest that
the AQP proteins endogenously expressed in the 3T3L1 adipocyte
plasma membrane were internalized under the control of CGI-58.
T. Miyauchi et al. / FEBS Letters 589 (2015) 608–614 6134. Discussion
Pharmacological modulation of glycerol concentration in adipo-
cytes is a potential treatment for metabolic disorders. AQP7 is an
aquaglyceroporin that is expressed in adipose tissue and is involved
in fat metabolism of adipocytes. However, there is controversy
regarding the expression proﬁle of AQP7. Using parafﬁn sections
from mouse adipose tissue, we are unable to detect labeling for
AQP7 in adipocytes; instead distinct labeling for AQP7 is found in
capillary endothelial cells [17]. A similar expression proﬁle was
observed in human adipose tissue [30]. Conversely, immunostain-
ing for AQP7 in adipocyte cell culture models predominantly labels
intracellular regions [10]. AQP7 mRNA and proteins were detected
in the fractionation of human adipocytes and stromovascular frac-
tion cells [31]. Furthermore, the phenotypes of AQP7-null mice sug-
gest that this protein has cell-autonomous functions in adipocytes.
In this study, we determined the localization and translocation
of AQP7 in adipose tissue. AQP7 was expressed in adipocytes and
capillary endothelia, albeit at lower levels in the former than in
the latter. A plausible explanation for the difference between our
previous studies and the current study is that different methods
were used for sample preparation (e.g., TCA ﬁxation). Next, we
observed that AQP7 re-localized from cortical to intracellular
membranes during catecholamine-stimulated lipolysis. By con-
trast, a previous study reported that AQP7 predominantly localizes
to intracellular regions and that AQP7 translocates from intracellu-
lar to cortical regions in a lipolysis-dependent manner [10]. To
overcome imaging limitations when investigating the subcellular
localization in adipocytes, we examined newborn mouse adipo-
cytes containing several small LDs in a single cell, and we opti-
mized the immunohistochemical method. In addition, live cell
imaging using 3T3-L1 adipocytes showed the dynamic transloca-
tion of AQP7. Thus, the primary conclusion of this study is that
AQP7 is expressed in white adipocytes and translocates from cor-
tical to inner membranes during lipolysis.
Aquaporin-2 is phosphorylated by PKA in response to antidi-
uretic hormone, and translocates from intracellular vesicles to
the plasma membrane in the principal cells of the renal collecting
ducts [32]. In both human and mouse AQP7, six prospective sites
for PKA phosphorylation have been identiﬁed based on database
analysis [33]. However, the direct regulation by PKA has not yet
been found. The phosphorylation-dependent translocation of
AQP7 remains to be elucidated.
The localization of AQP7 was affected by PKA and CGI-58. Dur-
ing catecholamine-stimulated lipolysis, CGI-58 reportedly tran-
siently dissociates from LDs, while CGI-58 functions as an ATGL
co-activator on LD surfaces. Here, we propose a dual mechanism
by which CGI-58 regulates lipolysis; CGI-58 increases ATGL activity
and induces the internalization of AQP7. This dual mechanism is
consistent with the observation that CGI-58 malfunctions have
more severe consequences than ATGL malfunctions [34–37].
Having described the dynamic subcellular localization of AQP7,
we propose the following signaling mechanism by which AQP7
controls lipid metabolism in adipocytes. AQP7 functions as a glyc-
erol channel at the plasma membrane, facilitating both glycerol
inﬂux and efﬂux in adipocytes, and affects the chemical equilib-
rium of lipolysis by reducing the local glycerol concentration
around the ER and LDs. Further studies are required to determine
the mediator(s) between AQP7 and CGI-58 and to illustrate the
glycerol distribution in adipocytes.
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